Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

150.82
Delayed Data
As of Jul 05
 +2.48 / +1.67%
Today’s Change
117.58
Today|||52-Week Range
212.00
-11.06%
Year-to-Date
No recent news for Alnylam Pharmaceuticals Inc.

Today’s Trading

Previous close148.25
Today’s open146.96
Day’s range145.06 - 151.22
Volume800,217
Average volume (3 months)880,512
Market cap$17.9B
Data as of 4:00pm ET, 07/05/2022

Growth & Valuation

Earnings growth (last year)+3.54%
Earnings growth (this year)+6.90%
Earnings growth (next 5 years)+38.33%
Revenue growth (last year)+71.31%
P/E ratioNM
Price/Sales23.79
Price/Book30.29

Competitors

 Today’s
change
Today’s
% change
INCYIncyte Corp+1.58+2.03%
CTLTCatalent Inc-0.01-0.01%
HZNPHorizon Therapeutics...+1.92+2.38%
VTRSViatris Inc-0.21-1.96%
Data as of 4:00pm ET, 07/05/2022

Financials

Next reporting dateAugust 2, 2022
EPS forecast (this quarter)-$1.63
Annual revenue (last year)$844.3M
Annual profit (last year)-$852.8M
Net profit margin-101.01%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Cambridge, Massachusetts

Forecasts